These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 28406518)

  • 41. Enzyme inhibition by hydroamination: design and mechanism of a hybrid carmaphycin-syringolin enone proteasome inhibitor.
    Trivella DB; Pereira AR; Stein ML; Kasai Y; Byrum T; Valeriote FA; Tantillo DJ; Groll M; Gerwick WH; Moore BS
    Chem Biol; 2014 Jun; 21(6):782-91. PubMed ID: 24930969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design and synthesis of FAJANU: a de novo C(2) symmetric cyclopeptide family.
    Garcia-Martin F; Cruz LJ; Rodriguez-Mias RA; Giralt E; Albericio F
    J Med Chem; 2008 Jun; 51(11):3194-202. PubMed ID: 18461923
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Peptide Backbone Stapling Strategy Enabled by the Multicomponent Incorporation of Amide N-Substituents.
    Ricardo MG; Marrrero JF; Valdés O; Rivera DG; Wessjohann LA
    Chemistry; 2019 Jan; 25(3):769-774. PubMed ID: 30412333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and biological property of carba and 20-deoxo analogues of arenastatin A.
    Murakami N; Wang W; Tamura S; Kobayashi M
    Bioorg Med Chem Lett; 2000 Aug; 10(16):1823-6. PubMed ID: 10969977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monocyclic Peptides: Types, Synthesis and Applications.
    Khazaei-Poul Y; Farhadi S; Ghani S; Ahmadizad SA; Ranjbari J
    Curr Pharm Biotechnol; 2021; 22(1):123-135. PubMed ID: 31987019
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthetic surfactin analogues have improved anti-PEDV properties.
    Yuan L; Zhang S; Peng J; Li Y; Yang Q
    PLoS One; 2019; 14(4):e0215227. PubMed ID: 30973929
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Total synthesis of desoxycyclomarin C and the cyclomarazines A and B.
    Barbie P; Kazmaier U
    Org Biomol Chem; 2016 Jul; 14(25):6055-64. PubMed ID: 27241664
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Limonin as a Starting Point for the Construction of Compounds with High Scaffold Diversity.
    Furiassi L; Tonogai EJ; Hergenrother PJ
    Angew Chem Int Ed Engl; 2021 Jul; 60(29):16119-16128. PubMed ID: 33973348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stereoselective total synthesis and structural elucidation of (-)-indoxamycins A-F.
    He C; Zhu C; Wang B; Ding H
    Chemistry; 2014 Nov; 20(46):15053-60. PubMed ID: 25262815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel echinocandin antifungals. Part 2: Optimization of the side chain of the natural product FR901379. Discovery of micafungin.
    Tomishima M; Ohki H; Yamada A; Maki K; Ikeda F
    Bioorg Med Chem Lett; 2008 May; 18(9):2886-90. PubMed ID: 18424132
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and biological evaluation of cryptophycin analogs with substitution at C-6 (fragment C region).
    Varie DL; Shih C; Hay DA; Andis SL; Corbett TH; Gossett LS; Janisse SK; Martinelli MJ; Moher ED; Schultz RM; Toth JE
    Bioorg Med Chem Lett; 1999 Feb; 9(3):369-74. PubMed ID: 10091686
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Total synthesis of rapamycin.
    Ley SV; Tackett MN; Maddess ML; Anderson JC; Brennan PE; Cappi MW; Heer JP; Helgen C; Kori M; Kouklovsky C; Marsden SP; Norman J; Osborn DP; Palomero MA; Pavey JB; Pinel C; Robinson LA; Schnaubelt J; Scott JS; Spilling CD; Watanabe H; Wesson KE; Willis MC
    Chemistry; 2009; 15(12):2874-914. PubMed ID: 19204960
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis of Lactam-Bridged and Lipidated Cyclo-Peptides as Promising Anti-Phytopathogenic Agents.
    Vasco AV; Brode M; Méndez Y; Valdés O; Rivera DG; Wessjohann LA
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32069902
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure--activity relationships of side-chain modified didemnins.
    Ding X; Vera MD; Liang B; Zhao Y; Leonard MS; Joullié MM
    Bioorg Med Chem Lett; 2001 Jan; 11(2):231-4. PubMed ID: 11206466
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ring A-modified Derivatives from the Natural Triterpene 3-O-acetyl-11-keto-β-Boswellic Acid and their Cytotoxic Activity.
    Li T; Fan P; Ye Y; Luo Q; Lou H
    Anticancer Agents Med Chem; 2017; 17(8):1153-1167. PubMed ID: 27928954
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Linear TMC-95-based proteasome inhibitors.
    Basse N; Piguel S; Papapostolou D; Ferrier-Berthelot A; Richy N; Pagano M; Sarthou P; Sobczak-Thépot J; Reboud-Ravaux M; Vidal J
    J Med Chem; 2007 Jun; 50(12):2842-50. PubMed ID: 17511440
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design and synthesis of 12-aza-epothilones (azathilones)--"non-natural" natural products with potent anticancer activity.
    Feyen F; Gertsch J; Wartmann M; Altmann KH
    Angew Chem Int Ed Engl; 2006 Sep; 45(35):5880-5. PubMed ID: 16871640
    [No Abstract]   [Full Text] [Related]  

  • 58. Total synthesis and anti-tubulin activity of epi-c3 analogues of cryptophycin-24.
    Buck SB; Huff JK; Himes RH; Georg GI
    J Med Chem; 2004 Jul; 47(14):3697-9. PubMed ID: 15214797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and Cytotoxicity of Cyclic Octapeptide Surugamides with Varied N-Acyl Moieties.
    Matsuda K; Niikura S; Ichihara R; Fujita K; Strasser AM; Yoshikawa R; Yasuda J; Hiramatsu Y; Hayashi H; Kodama EN; Wakimoto T
    Chem Pharm Bull (Tokyo); 2024; 72(9):826-830. PubMed ID: 39313387
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Total synthesis of the natural HDAC inhibitor Cyl-1.
    Servatius P; Kazmaier U
    Org Biomol Chem; 2018 May; 16(18):3464-3472. PubMed ID: 29687119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.